Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
Holding INTI?
Track your performance easily
INTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.18
Previous Close$0.09
Volume2.90K
Average Volume (3M)33.25K
Market Cap
$14.65M
Enterprise Value$7.55M
Total Cash (Recent Filing)$7.10M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.41
Next Earnings
May 01, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding172,323,545
10 Day Avg. Volume18,362
30 Day Avg. Volume33,246
Standard Deviation0.42
R-Squared0.00605
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)4.25
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-7.90
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INTI FAQ
What was Inhibitor Therapeutics Inc.’s price range in the past 12 months?
Inhibitor Therapeutics Inc. lowest stock price was $0.03 and its highest was $0.17 in the past 12 months.
What is Inhibitor Therapeutics Inc.’s market cap?
Currently, no data Available
When is Inhibitor Therapeutics Inc.’s upcoming earnings report date?
Inhibitor Therapeutics Inc.’s upcoming earnings report date is May 01, 2018 which is 2380 days ago.
How were Inhibitor Therapeutics Inc.’s earnings last quarter?
Currently, no data Available
Is Inhibitor Therapeutics Inc. overvalued?
According to Wall Street analysts Inhibitor Therapeutics Inc.’s price is currently Overvalued.
Does Inhibitor Therapeutics Inc. pay dividends?
Inhibitor Therapeutics Inc. does not currently pay dividends.
What is Inhibitor Therapeutics Inc.’s EPS estimate?
Inhibitor Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inhibitor Therapeutics Inc. have?
Inhibitor Therapeutics Inc. has 172,323,550 shares outstanding.
What happened to Inhibitor Therapeutics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Inhibitor Therapeutics Inc.?
Currently, no hedge funds are holding shares in INTI
---
Inhibitor Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
66.66%
12-Months-Change
Fundamentals
Return on Equity
-53.65%
Trailing 12-Months
Asset Growth
-29.38%
Trailing 12-Months
Company Description
Inhibitor Therapeutics Inc.
Inhibitor Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which discovers, develops and plans to commercialize therapeutics for patients with cancer. It also explores acquiring or licensing therapeutics addressing unmet needs and orphan indications beyond cancer. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.
---
Technical Analysis
---